Senseonics Holdings (SENS) Research & Development (2015 - 2026)
Senseonics Holdings' (SENS) quarterly Research & Development came in at $8.6 million in Q1 2026, up 17.98% year-on-year from $7.3 million in Q1 2025, and down 2.36% on a QoQ basis from $8.8 million in Q4 2025.
Senseonics Holdings (SENS) Research & Development (2015 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 12 years of Research & Development data on file, last reported at $8.6 million in Q1 2026.
- On a quarterly basis, Research & Development rose 17.98% year-over-year to $8.6 million in Q1 2026; TTM through Mar 2026 was $32.9 million, a 13.42% decrease from a year earlier, with the FY2025 full-year figure at $31.6 million, down 23.22% from the prior year.
- Research & Development for Q1 2026 stood at $8.6 million, down from $8.8 million in the prior quarter.
- Over the last five years, Research & Development for SENS reached as high as $12.8 million in Q2 2023 and fell as low as -$37.7 million in Q4 2023.
- Historically, Research & Development has averaged $7.1 million across 5 years, with a median of $9.4 million in 2024.
- Across the five-year window, Research & Development plunged 424.16% in 2023 and soared 124.83% in 2024, its largest moves.
- Year by year, Research & Development stood at $11.6 million in 2022, then plunged by 424.16% to -$37.7 million in 2023, then jumped by 124.83% to $9.4 million in 2024, then declined by 5.78% to $8.8 million in 2025, then declined by 2.36% to $8.6 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $8.6 million in Q1 2026, $8.8 million in Q4 2025, and $7.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Senseonics Holdings | 203.54 Mn | 139.22 Mn | 6.94 Mn | 8.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.61 Mn |
| Dec 31, 2025 | 8.82 Mn |
| Sep 30, 2025 | 7.76 Mn |
| Jun 30, 2025 | 7.72 Mn |
| Mar 31, 2025 | 7.30 Mn |
| Dec 31, 2024 | 9.36 Mn |
| Sep 30, 2024 | 10.55 Mn |
| Jun 30, 2024 | 10.80 Mn |
| Mar 31, 2024 | 10.44 Mn |
| Dec 31, 2023 | -37.70 Mn |
| Sep 30, 2023 | 12.77 Mn |
| Jun 30, 2023 | 12.83 Mn |
| Mar 31, 2023 | 12.41 Mn |
| Dec 31, 2022 | 11.63 Mn |
| Sep 30, 2022 | 10.99 Mn |
| Jun 30, 2022 | 9.30 Mn |
| Mar 31, 2022 | 7.80 Mn |
| Dec 31, 2021 | 7.66 Mn |
| Sep 30, 2021 | 7.20 Mn |
| Jun 30, 2021 | 7.11 Mn |